Asia Pacific Health Economics and Outcome Research (HEOR) Services Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The Asia Pacific health economics and outcome research (HEOR) services market size is expected to reach US$ 540.54 million by 2031 from US$ 228.23 million in 2024. The market is estimated to record a CAGR of 14.8% from 2024 to 2031.

Executive Summary and Asia Pacific Health Economics and Outcome Research (HEOR) Services Market Analysis:

The Asia Pacific is becoming the fastest-growing Health Economics and Outcomes Research (HEOR) market globally. Immense contributions from major countries like China, India, and Japan mainly drive this growth. These countries are witnessing increased demand for HEOR services due to mounting efforts toward cost optimization in healthcare systems. Healthcare professionals and decision-makers are using HEOR to optimize clinical procedures, support better decisions, and drive patient outcomes. Favorable government policies throughout the region further fuel this expansion, attracting investments and speeding up the implementation of HEOR practices. The increasing volume of clinical trials in the Asia Pacific is also generating significant opportunities for HEOR service providers to deliver valuable evidence on treatment efficacy and economic burden. As regional healthcare systems develop further with a focus on value-based care, there will be greater demand for end-to-end HEOR services, driving the Asia Pacific to become a key health economics and outcomes research hub for the world.

Asia Pacific Health Economics and Outcome Research (HEOR) Services Market: Strategic Insights

Asia Pacific Health Economics and Outcome Research (HEOR) Services Market Segmentation Analysis:

Key segments that contributed to the derivation of the Asia Pacific health economics and outcome research (HEOR) services market analysis are service, service provider, and end user.

• Based on service, the Asia Pacific health economics and outcome research (HEOR) services market is segmented into economic modelling or evaluation, real world data analysis and information system, market access solutions and reimbursement, clinical outcome, and others. The economic modelling or evaluation segment held the largest share of the market in 2024.

• By service provider, the Asia Pacific health economics and outcome research (HEOR) services market is bifurcated into contract research organizations and consultancy. The contract research organizations segment held a larger share of the market in 2024.

• By end user, the Asia Pacific health economics and outcome research (HEOR) services market is segmented into biotechnology and pharmaceutical companies, healthcare payers, government organizations, and healthcare providers. The biotechnology and pharmaceutical companies segment held the largest share of the market in 2024.

Asia Pacific Health Economics and Outcome Research (HEOR) Services Market Players Density: Understanding Its Impact on Business Dynamics

The Asia Pacific Health Economics and Outcome Research (HEOR) Services Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Asia Pacific Health Economics and Outcome Research (HEOR) Services Market Outlook

Precision medicine is an emerging segment in the healthcare industry. Research and developments have shown promising results in the betterment of people and health improvement. However, despite various developments and improvements, there is a lack of evidence, thresholds, and reimbursement scenarios. Various researchers, payers, healthcare service providers, and market players are working to deploy new insights into personalized or precision medicine applications in early drug development and their consequences for health technology assessment. These provide ample growth opportunities for HEOR service providers to enhance their services for strategy and consulting, real-world evidence, modeling and microsimulation, and evidence synthesis associated with precision medicine. In addition, the HEOR guidelines and frameworks can clarify the outcomes and their impacts caused by regulatory and reimbursement policies for precision medicine applications. Moreover, they are expected to guide research investments to improve the appropriate use of precision medicine. Thus, the emergence of precision medicine is expected to provide vital growth opportunities for the market during the forecast period.

Asia Pacific Health Economics and Outcome Research (HEOR) Services Market Country Insights

Based on country, the Asia Pacific health economics and outcome research (HEOR) services market comprises China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China held the largest share in 2024.

China has a vast population and has flourished healthcare infrastructure, with rapid growth in communication. The government in China is actively engaged in providing advanced solutions to improve the quality of healthcare. In addition, increasing investments in drug discovery as well as healthcare optimizations are likely to contribute to the growth of China's health economic and outcomes research services market during the forecast period. In September 2020, Pfizer announced its proposed plan to invest US$ 200 million in China-based biotechnology company CStone Pharmaceuticals. The collaboration is planning to develop cancer therapeutics. Such collaborations are estimated to drive the demand for HEOR solutions in the country.

Academic institutes and research centers are also emphasizing on adoption of HEOR services in order to make data-driven strategic decisions. In February 2021, the collaboration between the Analysis Group and the Institute of Hematology & Blood Diseases Hospital, a clinical research center of the Chinese Academy of Medical Sciences, and Peking Union Medical College announced positive results of their studies regarding hemophilia in China. The research institute is utilizing real-world evidence solutions provided by Analysis Group to make data-driven decisions. Further, the government of China is actively investing and prioritizing the use of HEOR solutions to validate the product market access. For instance, in April 2020, Allergan plc received approval for its XEN gel stent from China's National Medical Products Administration. The approving authority used real world evidence solutions in order to validate the product applications.

Asia Pacific Health Economics and Outcome Research (HEOR) Services Market Company Profiles

Some of the key players operating in the market include PharmaLex GmbH; ICON Plc; IQVIA Holdings Inc; Syneos Health Inc; Optum Inc; Certara Inc.; ExlService Holdings, Inc.; Avalon Health Economics LLC; Axtria, Inc.; and McKesson Corp, among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Asia Pacific Health Economics and Outcome Research (HEOR) Services Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations.

• Industry trade journals and other relevant publications.

• Government documents, statistical databases, and market reports.

• News articles, press releases, and webcasts specific to companies operating in the market.

Note:

All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research.

• Enhance the expertise and market understanding of the analysis team.

• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers

• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise